Survey by BioScience Laboratories Finds 68% of Subject Pool Pre-qualified for Upcoming Phase I Clinical Trials

    BOZEMAN, MT, February 25, 2009 /24-7PressRelease/ -- The results of a recent survey by BioScience Laboratories to prepare its subject base for upcoming Phase I clinical trials, indicated that 68% of its active subjects pre-qualify for Phase I clinical trials. To be considered pre-qualified, subjects must be at least 18 years of age, have a BMI between 18 and 30, be physically willing and able to participate, and not be taking any prescription medications. BioScience Laboratories recruits its subjects from a population of over 100,000 in Southwest Montana. This population includes persons of a variety of ethnic origins -- Asian, Caucasian, Latino, Native American and others -- with a median age of 25.

BioScience Laboratories, a Contract Research Organization for Phase I Clinical Trials, including bioavailability and bioequivalence studies, has performed over 1,500 clinical studies ranging in size from 40 to 400 subjects during its eighteen year history. BioScience Laboratories maintains a GCP-compliant clinical laboratory that has been successfully audited by both our clients and the FDA and has filled studies in as quickly as four hours. To protect the well-being and health of the subjects, BioScience Laboratories employs the services of the Gallatin Institutional Review Board, which is comprised of healthcare and other professionals who review all clinical study protocols. This board is registered and has been audited by the Food and Drug Administration.

For additional information, contact:
Sabrina Bakich
BioScience Laboratories, Inc.
1-877-858-2754
FAX 406-586-7930
[email protected]
www.biosciencelabs.com

About BioScience Laboratories, Inc.

BioScience Laboratories, Inc. was founded in 1991 in Bozeman, MT, to provide antimicrobial product testing and result interpretation grounded in science. Bioscience Laboratories Inc. strives to assist its clients in strengthening their current market positions through product testing and aid in the development of new products and new markets. Today, BioScience Laboratories offers state-of-the art clinical study and laboratory services and guidance regarding federal regulatory agency requirements for the healthcare, pharmaceutical, personal care and consumer products markets.

# # #